CS
NRSNW icon

Clear Street’s NeuroSense Therapeutics Warrant NRSNW Stock Holding History

Clear Street’s Portfolio NRSNW Stock Details NRSNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.7K Hold
63,385
– – ﹤0.01% 933
2025
Q4 		$20.3K Sell
63,385
-300
-0.5% -$107 ﹤0.01% 718
2025
Q3 		$24.2K Hold
63,685
– – ﹤0.01% 616
2025
Q2 		$40.4K Sell
63,685
-2,074
-3% -$809 ﹤0.01% 376
2025
Q1 		$13.5K Buy
65,759
+100
+0.2% +$26 ﹤0.01% 344
2024
Q4 		$28.9K Sell
65,659
-100
-0.2% -$27 ﹤0.01% 233
2024
Q3 		$9.87K Buy
65,759
+6,487
+11% +$1.1K ﹤0.01% 388
2024
Q2 		$12.2K Buy
59,272
+100
+0.2% +$23 ﹤0.01% 408
2024
Q1 		$24.9K Sell
59,172
-100
-0.2% -$25 ﹤0.01% 283
2023
Q4 		$4.63K Hold
59,272
– – ﹤0.01% 459
2023
Q3 		$9.18K Buy
59,272
+600
+1% +$109 ﹤0.01% 550
2023
Q2 		$13.9K Buy
58,672
+2,001
+4% +$630 ﹤0.01% 643
2023
Q1 		$22.1K Sell
56,671
-125
-0.2% -$40 ﹤0.01% 363
2022
Q4 		$9K Buy
56,796
+293
+0.5% +$74 ﹤0.01% 540
2022
Q3 		$11K Buy
56,503
+4,045
+8% +$1.04K ﹤0.01% 591
2022
Q2 		$27K Buy
52,458
+12,320
+31% +$5.08K ﹤0.01% 352
2022
Q1 		$24K Buy
+40,138
New +$25.4K ﹤0.01% 189

Other funds holding NRSNW

EAM
Empery Asset Management New York $83M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clear Street's NRSNW Position: Q1 2026 in Review

Clear Street held its NeuroSense Therapeutics Warrant (NRSNW) position steady in Q1 2026 at 63,385 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #933.

Clear Street first reported a position in NRSNW in Q1 2022 and has held it in 17 quarters since. The position peaked at $40.4K in Q2 2025. 3 funds tracked by Wall St. Rank hold NRSNW as of Q1 2026.

  • Clear Street held 63,385 shares of NeuroSense Therapeutics Warrant worth $12.7K as of Q1 2026.
  • Clear Street left its NeuroSense Therapeutics Warrant share count unchanged in Q1 2026.
  • NeuroSense Therapeutics Warrant made up ﹤0.01% of Clear Street's portfolio in Q1 2026, its #933 holding.
  • Clear Street first reported a position in NeuroSense Therapeutics Warrant in Q1 2022 and has held it in 17 quarters since.
  • Clear Street's NeuroSense Therapeutics Warrant position peaked at $40.4K in Q2 2025.
  • 3 funds tracked by Wall St. Rank held NeuroSense Therapeutics Warrant as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.